Financials PT Suparma Tbk

Equities

SPMA

ID1000054307

Paper Products

End-of-day quote INDONESIA S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
302 IDR -1.95% Intraday chart for PT Suparma Tbk -6.21% -13.22%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 524,414 706,267 655,517 1,953,863 1,564,430 1,097,624
Enterprise Value (EV) 1 1,123,958 1,246,501 1,037,500 2,394,353 1,980,887 1,403,490
P/E ratio 6.38 x 5.39 x 4.03 x 5.78 x 4.65 x 6.14 x
Yield - - 4.84% - - -
Capitalization / Revenue 0.22 x 0.28 x 0.3 x 0.7 x 0.5 x 0.41 x
EV / Revenue 0.47 x 0.5 x 0.48 x 0.86 x 0.63 x 0.53 x
EV / EBITDA 3.8 x 4.49 x 3.22 x 4.75 x 3.21 x 3.99 x
EV / FCF 8.81 x -241 x 8.66 x 21,854 x 13.9 x 7.83 x
FCF Yield 11.3% -0.41% 11.6% 0% 7.19% 12.8%
Price to Book 0.42 x 0.51 x 0.43 x 1.08 x 0.73 x 0.47 x
Nbr of stocks (in thousands) 3,154,094 3,154,094 3,154,094 3,154,094 3,154,092 3,154,092
Reference price 2 166.3 223.9 207.8 619.5 496.0 348.0
Announcement Date 3/28/19 6/16/20 3/26/21 3/26/22 3/31/23 4/1/24
1IDR in Million2IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,389,269 2,514,161 2,151,495 2,794,453 3,138,054 2,658,521
EBITDA 1 295,782 277,540 322,223 503,972 617,539 352,014
EBIT 1 208,400 188,422 228,817 412,683 526,794 255,063
Operating Margin 8.72% 7.49% 10.64% 14.77% 16.79% 9.59%
Earnings before Tax (EBT) 1 109,673 176,640 195,503 377,510 431,446 237,849
Net income 1 82,233 131,006 162,525 294,326 336,138 178,658
Net margin 3.44% 5.21% 7.55% 10.53% 10.71% 6.72%
EPS 2 26.07 41.54 51.53 107.1 106.6 56.64
Free Cash Flow 1 127,514 -5,164 119,861 109.6 142,524 179,253
FCF margin 5.34% -0.21% 5.57% 0% 4.54% 6.74%
FCF Conversion (EBITDA) 43.11% - 37.2% 0.02% 23.08% 50.92%
FCF Conversion (Net income) 155.07% - 73.75% 0.04% 42.4% 100.33%
Dividend per Share - - 10.06 - - -
Announcement Date 3/28/19 6/16/20 3/26/21 3/26/22 3/31/23 4/1/24
1IDR in Million2IDR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 599,544 540,234 381,983 440,490 416,457 305,866
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.027 x 1.947 x 1.185 x 0.874 x 0.6744 x 0.8689 x
Free Cash Flow 1 127,514 -5,164 119,861 110 142,524 179,253
ROE (net income / shareholders' equity) 6.78% 9.95% 11.2% 17.6% 17% 8%
ROA (Net income/ Total Assets) 5.84% 5.06% 6.1% 10.2% 11% 4.87%
Assets 1 1,407,444 2,589,250 2,663,989 2,888,320 3,055,359 3,666,516
Book Value Per Share 2 398.0 437.0 486.0 576.0 680.0 735.0
Cash Flow per Share 2 76.20 65.80 35.40 62.60 95.20 98.90
Capex 1 50,973 132,575 297,931 47,036 57,054 31,718
Capex / Sales 2.13% 5.27% 13.85% 1.68% 1.82% 1.19%
Announcement Date 3/28/19 6/16/20 3/26/21 3/26/22 3/31/23 4/1/24
1IDR in Million2IDR
Estimates
  1. Stock Market
  2. Equities
  3. SPMA Stock
  4. Financials PT Suparma Tbk
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW